177 related articles for article (PubMed ID: 21207044)
1. Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia.
Korkmaz L; Erkuş E; Kırış A; Ağaç MT; Acar Z; Turan T; Erkan H; Dursun I; Celik S
Clin Res Cardiol; 2011 Jun; 100(6):511-4. PubMed ID: 21207044
[TBL] [Abstract][Full Text] [Related]
2. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
Zhang H; Gao Y; Wu D; Zhang D
BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
7. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
9. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
[TBL] [Abstract][Full Text] [Related]
11. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
[TBL] [Abstract][Full Text] [Related]
12. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
16. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
Ling Y; Tang S; Cao Y; Fu C
Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
[TBL] [Abstract][Full Text] [Related]
19. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
[TBL] [Abstract][Full Text] [Related]
20. Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.
Zheng D; Zeng F; Cai A; Liao H; Liu L; Qiu R; Xu R; Xiao C; Mai W
Lipids Health Dis; 2014 Mar; 13():41. PubMed ID: 24580749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
